Rhizen Pharmaceuticals
-
Alembic’s associate Rhizen’s cancer drug Umbralisib gets US FDA nod
The price of the drug in the US will be close to $16,000 for one month for a patient Drug…
Read More » -
Rhizen Pharma gets US FDA approval COVID-19 drug trials
The initial study would evaluate single ascending doses of the RP7214 in healthy volunteers Rhizen Pharmaceuticals, an associate company of…
Read More » -
Alembic Pharma arm inks pact with Curon
Drug firm Alembic Pharma said its associate company, Rhizen Pharmaceuticals, has entered an exclusive license agreement with Curon Biopharmaceutical for…
Read More »